The present disclosure relates to the production of sialylated Human Milk Oligosaccharides (HMOs), in particular to the biosynthetic production of 3′-sialyllactose (3′SL), and to genetically engineered cells and methods suitable for said production.
C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
Rosa RoxbunghiiRosa Roxbunghii and a method of preparation thereof. The freeze-dried powder of the present invention surprisingly provides light-color, uniform and stable cake appearance in penicillin vial and efficiently prevents degradation of vitamin C comprised in the powder.
The present invention relates to the use of a mixture of a) 2'-fucosyllactose (2'-FL) or 3'-sialyllactose (3'-SL); and b) a compound selected from the group consisting of group consisting of 3-[(2-ethylhexyl)oxy]-1,2-propanediol (=ethylhexylglycerin), propane-1,2-diol, propane-1,3-diol, glyceryl caprylate, pentane-1,2-diol, heptane-1,2-diol and hydroxyacetophenone for reducing the growth of microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
The present invention relates to a meat analogue product comprising a texturized vegetable protein, a binder, a flavor and 0.5 to 10% (w/w) of a yeast single cell protein product, wherein the yeast single cell protein product comprises Saccharomycetales yeast cells or parts thereof.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of at least one probiotic strain and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to a new formulation, which comprises a high amount of retinol, which has a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
The present invention relates to cosmetic compositions comprising a combination of lacto-N-tetraose (LNT) or lacto-N-neotetraose (LNnT); and an aliphatic diol or aliphatic triol or an ether or an ester thereof. These cosmetic compositions, respectively said combinations, show a significant antimicrobial effect on microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
The present invention relates to cosmetic compositions comprising a combination of lacto-N-tetraose (LNT) or lacto-N-neotetraose (LNnT); and hydroxyacetophenone. Said cosmetic compositions, respectively said combinations show a significant antimicrobial effect on microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
9.
SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH
The invention relates to a method for recovery and purification of human milk oligosaccharides (HMOs) from a fermentation broth, comprising the steps of separating the fermentation broth to form a separated HMO-containing stream and a biomass waste stream, purifying the separated HMO-containing stream, concentrating the purified HMO-containing stream, and drying the purified HMO-containing stream to obtain solidified HMO. Moreover, the invention also concerns a human milk oligosaccharide obtained by the inventive method, as well as its use in food, feed, and medical application.
The present disclosure provides a method for increasing production of a polyunsaturated fatty acid, especially eicosapentaenoic acid (EPA), in a microorganism, comprising adjusting the macro-and/or micronutrients during fermentation. The invention includes any culture, biomass, and oil produced by the method.
The present disclosure relates to the production of complex fucosylated Human Milk Oligosaccharides (HMOs) and in particular to the production of the complex fucosylated HMO LNFP-VI or LNFP-V, with five or more monosaccharide units, where said production leads to a product which is essentially free of LNFP-III and LNDFH-III, or LNFP-II and LNADH-II, respectively using alpha-1,3-fucosyltransferases from Bacteroidales bacterium. The present disclosure also relates to genetically engineered cells and alpha-1,3-fucosyltransferases suitable for use in said production, as well as to methods for producing said fucosylated HMOs.
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Hydrocolloids, gelling agents, thickening agents,
stabilizers, emulsifiers, binding agents, gums, modified
starches, pectins and fibers for use in the manufacture of
food and beverage products, pharmaceuticals, personal care
products and cosmetics.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Additives for food and beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
cultures and fermented preparations of microorganisms for
industrial use for the production of food, beverages, namely
DHA algae oil (docosahexaenoic acid) extracted from algae
strains; chemical and biochemical preparations relating to
microbiologically produced products for industrial use for
the production of food, beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
additives for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; fatty
acids for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; plant
extracts, other than essential oils, for the food industry,
namely DHA algae oil (docosahexaenoic acid) extracted from
algae strains.
Methods for sustainably producing a pet food product and the pet food products thereby produced include formulating a pet food product by replacing all or part of fish oil in a pet food product composition with a single microbial source of eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”). In a preferred embodiment, the microbial source comprising DHA and EPA derives from a microorganism/microbe of the genus Schizochytrium or Thraustochytrium.
The disclosed inventions pertain to solid extrudates for pharmaceutical use. The solid extrudates comprise at least one cannabinoid isolate and may be produced by hot melt extrusion. In an embodiment, a solid extrudate comprises 20-40 wt% of a cannabinoid isolate, 20-40 wt% of a hydroxypropyl methylcellulose, 5-15 wt% of a monounsaturated fatty acid, and 10-30 wt% of a surfactant.
In an embodiment, a polyurethane comprises the residues of i. an aliphatic diisocyanate, ii. an aliphatic diol comprising a poly(ethylene oxide) moiety, iii. an aliphatic diol comprising a polycarbonate moiety, and iv. a chain extender, wherein the polyurethane has a melting temperature of 140° C. or less and has a weight average molecular weight of from 100,000 to 500,000 g/mol. In an embodiment, the polyurethane is substantially devoid of catalyst. In an embodiment, the polyurethane is formed by reactive extrusion. In an embodiment, a medical device comprises the polyurethane and a bioactive agent. The medical devices, methods, and polyurethanes may exhibit benefits in end-product biostability, drug release profile, health and safety, and processing speed or reproducibility.
A61L 31/06 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61L 29/06 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
C08G 18/12 - Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
The present invention discloses a LC-PUFA biomass composition which has reduced self-heating propensity and thus requires a lessened packing requirement for shipment. The invention also discloses methods for making such biomass composition.
C12N 1/00 - Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor
C12N 1/12 - Unicellular algaeCulture media therefor
The present invention relates to relates to the field of food. Disclosed is a method for preparing soy or almond protein comprising coffee or tea, comprising adding soy or almond protein to coffee or tea and wherein said soy or almond protein is a protein arginine deiminase (PAD) or proline-specific endoprotease (PSP) treated soy or almond protein.
A23C 11/10 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
The present invention relates to a process for reducing an amount of phospholipids in an oil composition using an enzyme having phospholipase A2 activity.
The present invention is related to a novel process on biological production of lipophilic substances in an oleaginous host cell, particularly Yarrowia lipolytica, comprising modification in the N-glycosylation pathway, leading to higher yield and product purity with further facilitating the overall production process.
C12P 23/00 - Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
The present invention relates to a method for modifying a trichothecene, a mutant variant of a polypeptide, an additive, methods for manufacturing, a use of the polypeptide, a polynucleotide, a recombinant host cell, and a polypeptide for use in treatment, amelioration and/or prophylaxis of symptoms caused by mycotoxicosis.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
Chemical and biochemical products and preparations for use in the manufacture of cosmetics, eye care products, hair care products, scalp care products, skin care products, body care products, make-up products, lip care products and sun care products; synthetic agents and biotech agents for use in the manufacture of cosmetics, eye care products, hair care products, scalp care products, skin care products, body care products, make-up products, lip care products and sun care products. Cosmetics and cosmetic preparations, also for make-up, beauty, eye care, scalp care, foot care, lip care, hair care, face care, body care, skin care and hand care; Cosmetics, make-up, eye care products, hair care products, scalp care products, foot care products, lip care products, face care products, body care products, skin care products and hand care products for the prevention of sunburn; Sun-tan and sun-screening preparations; sun care preparations.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Probiotic preparations for use in the dietary supplement
industry; prebiotic preparations for use in the dietary
supplement industry; postbiotic preparations for use in the
dietary supplement industry; probiotics for use in the
manufacture of nutraceuticals; prebiotics for use in the
manufacture of nutraceuticals; postbiotics for use in the
manufacture of nutraceuticals; probiotic and prebiotic
bacteria for the food industry; probiotic or prebiotic
bacterial formulations (other than for medical use);
cultures of microorganisms other than for medical or
veterinary use; bacteria, molecules and microorganisms for
addition to dietary supplements and food products. Dietary supplements; probiotic preparations for medical
purposes; prebiotic supplements; probiotic supplements;
postbiotic supplements; microbiome preparations for dietary
purposes.
24.
MICROBIAL STRAIN EXPRESSING AN INVERTASE/SUCROSE HYDROLASE
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The identification of efficient enzymes capable of hydrolysing sucrose in its non-modified form, and which on its own enable the cell to utilize sucrose as a, or as the main and/or sole, carbon and/or energy source, i.e., without the need for multi-gene sucrose utilizing systems comprising several other heterologous polypeptides, such as other enzymes and/or transporters, is highly advantageous, since it allows for cost-effective use of sucrose in large scale production processes.
PROCESS FOR PRODUCING A FERMENTED MILK PRODUCT WITH AID OF STRAINS OF STREPTOCOCCUS THERMOPHILUS HAVING NO OR LIMITED SALT-ACCOMPANIED NISIN-DEACTIVATING ACTIVITY
The present invention relates to a new process for producing a fermented milk product, preferably cheese. In addition, the present invention relates to a new bacterial culture, starter culture and kit of parts for use in such a process.
The present invention relates to a method of reducing methane emissions in ruminants, said method encompassing treating pre-/young ruminants with 3-nitrooxypropanol.
The present invention relates to a composition for aquatic animals comprising as active ingredient 25-hydroxyvitamin D, preferably 25-hydroxy vitamin D3 (25-OH D3). The present invention further relates to the use of 25-hydroxyvitamin D, preferably 25-hydroxyvitamin D3 (25-OH D3), as feed additive for aquatic animals including fish and shrimp. More particular, this invention relates to the use of 25-hydroxyvitamin D, preferably 25-hydroxyvitamin D3 (25-OH D3), for improving feed utilization and growth and performance parameters of the animals, such as the feed conversion ratio (FOR). Immunity, protein efficiency ratio (PER), specific growth rate (SGR), final body weight, feed efficiency (FE), nutrient utilization, body protein content, and/or carcass yield and/or for increasing levels of Vitamin D, preferably Vitamin D3, in the blood of aquatic animals.
A23K 40/25 - Shaping or working-up of animal feeding-stuffs by extrusion
A23K 40/30 - Shaping or working-up of animal feeding-stuffs by encapsulatingShaping or working-up of animal feeding-stuffs by coating
A23K 50/80 - Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
The present invention relates to improved carrier systems for 3-nitrooxypropanol and derivatives thereof as well as to the production of such formulations.
A23K 10/30 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms
The invention relates to non-liposomal lipid matrix-based particles of nutrients, particularly of water-soluble vitamins, showing a continuous release of the nutrient throughout the small intestine, and a method of manufacturing it. The non-liposomal lipid matrix-based particles of nutrients are intended for use in food, agricultural, personal care, cosmetic, manufacturing, or pharmaceutical applications, and particularly in supplementation applications.
A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
30.
USE OF WHEY AND PROPANEDIOL MONONITRATE TO REDUCE METHANE EMISSION OF RUMINANTS
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of whey and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
42 - Scientific, technological and industrial services, research and design
Goods & Services
chemical and biochemical preparations for use in skin care products, moisturizers, skin care products for the prevention of sunburn, sun creams, sun-tan products and sun-screen products for the absorption of ultraviolet. skin care products for the prevention of sunburn; sun-tan and sun-screening preparations; sun creams; cosmetics and skin care products; preparations and substances for the conditioning, care and appearance of the skin, body and face; moisturizers. advisory services relating to environmental pollution; advisory services relating to environmental protection; advisory services relating to the environmental safety of sun-tan and sun-screen products; provision of information on environmental safety of sun-tan and sun-screen products; industrial analysis and research services.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
chemical and biochemical preparations for use in skin care products, moisturizers, skin care products for the prevention of sunburn, sun creams, sun-tan products and sun-screen products for the absorption of ultraviolet. skin care products for the prevention of sunburn; sun-tan and sun-screening preparations; sun creams; cosmetics and skin care products; preparations and substances for the conditioning, care and appearance of the skin, body and face; moisturizers.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Hydrocolloids, gelling agents, thickening agents, stabilizers, emulsifiers, binding agents, gums, modified starches, pectins and fibers for use in the manufacture of food and beverage products, pharmaceuticals, personal care products and cosmetics
34.
METHODS OF SUPPORTING GASTROINTESTINAL HOMEOSTASIS
Methods of feeding animals are disclosed whereby feed additives are provided that modulate the gut microbiome to prevent or treat dysfunctions in a gastrointestinal barrier. The present disclosure further relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to prevent or treat infections.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; acids for use in the preparation of animal foodstuffs; surfactants for the production of animal feed; antioxidants for use in manufacturing processes for feed and feed supplements; proteins for use in animal feed and feed supplement manufacturing processes; vitamins for the production of feed and feed supplements; antioxidants for the production of feed and feed supplements; enzymes to assist in digestion for use in the manufacture of animal feeds; enzymes for use in the manufacture of feed and feed supplements; chemical additives for use in the preparation of animal foodstuffs; chemical additives for use in the manufacture of animal foodstuffs. Dietary supplements for animals; feed additives for animals; medicated supplements for foodstuffs for animals; feed supplements for veterinary use; feeding stimulants for animals; medicated animal feed; medicated additives for animal foods; probiotic supplements for animals; enzymes for veterinary purposes; enzyme dietary supplements for animals; amino acids for veterinary purposes; protein supplements for animals; bacterial preparations for veterinary purposes; herbal detoxification agents for animals; mineral dietary supplements for animals; nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed; animal feed preparations; yeast for animal fodder.
05 - Pharmaceutical, veterinary and sanitary products
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Dietary supplements and dietetic preparations; nutritional supplements; nutritional supplements for sports nutrition; nutritional supplement energy bars and gels; dietary food supplements in the nature of ready-to-eat protein bars; liquid nutritional supplements; protein shakes; nutritional recovery drinks; probiotic supplements; protein nutritional supplements; caffeine preparations for stimulative use. Fruit bars; nut bars; fruit and nut bars; milk based energy drinks. Energy bars; cereal bars; cereal-derived food bars; snack bars containing a mixture of grains, nuts and dried fruit; chocolate bars; high-protein cereal bars; pancakes.
The present invention relates to a meat analogue product comprising a texturized vegetable protein, a binder, a flavor and 0.5 to 10% (w/w) of a rapeseed protein isolate comprising napins and cruciferins, wherein the rapeseed protein isolate comprising napins and cruciferins is not texturized.
Synthetic biopolymers are disclosed, which can be engineered in terms of both their amino acid sequences and post-synthesis treatments to which they are subjected, to achieve desired gelation characteristics, particularly upon being exposed to physiological temperature (e.g., 37° C.). These synthetic biopolymers are therefore useful for injectable or implantable compositions for tissue repair, such as for bone void filler compositions. Examples of synthetic biopolymers are synthetic elastin-like polypeptides (ELPs) having polypeptide sequences with functional oligopeptide blocks that may include one or more hydrophobic blocks, one or more aggregation-enhancing blocks, and one or more β-sheet formation-inducing blocks. Optionally, one or more biomineralizing blocks may be present, to promote bone repair, growth, and/or strengthening.
A61L 27/46 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
Methods of making a composite fabric for use in or as a medical implant component are disclosed whereby the method includes the steps of providing a textile comprising at least one strand having titer of 2-250 dtex and comprising fibers made from a biocompatible and biostable synthetic polymer; determining locations on the textile where a cut is to be made for an intended use of the textile; optionally pretreating the textile at least at the determined locations on at least one side of the textile with a high-energy source to activate the surface; solution coating the textile at least at a determined location with a coating composition comprising a biocompatible and biostable polyurethane elastomer and a solvent for the polyurethane; removing the solvent from the coated textile; and laser cutting the coated textile as obtained at least a one coated location with an ultra-short pulse laser; to result in a composite biotextile wherein polyurethane is present in an amount of 2.5-90 mass % based on composite biotextile and polyurethane is present at least at a laser-cut edge.
D06N 3/00 - Artificial leather, oilcloth, or like material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof
D06N 3/14 - Artificial leather, oilcloth, or like material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds with polyurethanes
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Phenazopyridine hydrochloride preparations suitable as analgesics; Methenamine and Sodium Salicylate preparations suitable as analgesics and antibacterials; preparations for the treatment of yeast infections; homeopathic medicine
A computer-based method for determining a sunscreen composition comprising a plurality of UV filter substances, comprises the steps of selecting at least one constraint for at least one characteristic of the composition to be determined (step 30), the at least one constraint comprising a sunscreen performance target; selecting an optimization objective from a plurality of optimization objectives (step 50); and automatically determining the sunscreen composition as a composition of filter substances from a set of filter substances (step 100), the composition meeting the at least one constraint and being optimized with respect to the selected optimization objective. The automatic determination comprises the steps of generating a plurality of candidate compositions, determining a sunscreen performance of the candidate compositions using a performance simulation tool and comparing the determined sunscreen performance of the candidate compositions with the sunscreen performance target. The method allows for an automatic determination of an optimum sunscreen composition based on constraints and objectives, thus avoiding manual trial and error methods that are lengthy and do not always lead to the optimal result.
Disclosed embodiments concern a composition comprising mannan-derived oligosaccharides orycast cell wall product and vitamin C. vitamin E, vitamin D3, and selenium. The disclosedembodiments further concern a method of administering the above composition as a feedadditive to supplement the feed of. farm animals. particularly for sows and piglets. The disclosedmethod is for promoting the immunity of pigs.
C07C 29/42 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy groups, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
The present invention provides a method for reducing ammonia emission of animals comprising administering to the animals one or more proteolytic enzymes, i.e., proteases. The present invention also provides a feed composition suitable for the above methods and use thereof.
The present invention relates to a new formulation, which is a gummy product comprising a high amount of at least one oily ingredient. The gummy product includes an oily ingredient can be any oil/fat. Suitable oils/fats are i.e. any PUFA, a fat-soluble vitamin, any carotenoid, any cannabinoid oil. The disclosed invention also includes a process for producing said gummy product.
A23L 29/206 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin
A23D 7/00 - Edible oil or fat compositions containing an aqueous phase, e.g. margarines
A23G 3/02 - Apparatus specially adapted for manufacture or treatment of sweetmeats or confectioneryAccessories therefor
A23L 33/115 - Fatty acids or derivatives thereofFats or oils
A23L 29/256 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
47.
SINGLE CELL PROTEIN PRODUCTS WITH HIGH DIGESTIBILITY FOR USE AS AQUAFEED
The present invention relates to a composition comprising yeast single cell protein (SCP) product with a degree of hydrolysis of at least 12%, preferably at least 16%, more preferably at more preferably least 20%, more preferably at least 24%, most preferably at least 28%. Preferably, the yeast single cell protein product is used as a feed ingredient in aquaculture. The yeast single cell protein product is advantageously digestible in contrast to other proteins sources for aquaculture, such as fish meal.
The present invention relates to a method to prepare a high-protein (microbial) biomass or SCP from an alcohol feedstock. In particular, it is an object to provide a method for preparing such a high-protein (microbial) biomass wherein the oxygen transfer capacity is improved. The invention is directed to a method for the production of biomass, in particular single cell protein, wherein the yeast single cell protein product comprises Saccharomycetales yeast cells, as well as to an animal feed comprising such biomass.
A23J 3/20 - Proteins from microorganisms or unicellular algae
A23K 10/16 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
C12P 1/02 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using fungi
A23K 10/12 - Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
49.
SINGLE CELL PROTEIN PRODUCTS CONTAINING LOW LEVELS OF NUCLEIC ACIDS
The present invention relates to a composition comprising yeast single cell protein (SCP) product comprising at most about 6% or less (w/w) nucleic acid content per gram of dry yeast SCP product. Preferably, the yeast single cell protein product is produced utilizing ethanol or molasses as a feedstock. The yeast single cell protein product contains advantageously a high ratio of unsaturated versus saturated fatty acids.
The present invention relates to an improved method for cultivating a microorganism capable of utilizing ethanol as feedstock using continuous cultures. The invention is directed to an improved method for the production of biomass using continuous cultures, in particular single cell protein, wherein the yeast single cell protein product comprises Saccharomycetales yeast cells, as well as to an animal feed comprising such biomass.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Probiotic preparations for use in the dietary supplement industry; prebiotic preparations for use in the dietary supplement industry; postbiotic preparations for use in the dietary supplement industry; probiotics for use in the manufacture of nutraceuticals; prebiotics for use in the manufacture of nutraceuticals; postbiotics for use in the manufacture of nutraceuticals; probiotic and prebiotic bacteria for the food industry; probiotic or prebiotic bacterial formulations (other than for medical use); cultures of microorganisms other than for medical or veterinary use; bacteria, molecules and microorganisms for addition to dietary supplements and food products.
(2) Dietary supplements; probiotic preparations for medical purposes; prebiotic supplements; probiotic supplements; postbiotic supplements; microbiome preparations for dietary purposes.
The present invention relates a variant polypeptide having geranylgeranyl pyrophosphate synthase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a geranylgeranyl pyrophosphate synthase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids at positions 92, 100 or 235 said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having geranylgeranyl pyrophosphate synthase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
C12P 15/00 - Preparation of compounds containing at least three condensed carbocyclic rings
C12P 19/56 - Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
55.
MEANS AND METHODS FOR REDUCING ESTROGENIC EFFECT OF XENOESTROGEN
The present invention relates to a composition comprising a compound having formula (I), preferably selected from (E)-2,4-dihydroxy-6-(10-hydroxy-6-oxo-1-undecen-1-yl)benzoic acid or (E)-1-(3,5-dihydroxy-phenyl)-10-hydroxy-1-undecen-6-one, a method for reducing estrogenic effect(s) using said compound, use of said compound, and a composition comprising said compound for use in treatment, amelioration and/or prevention of symptoms associated with estrogenic effect(s) of a xenoestrogen.
A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A23K 10/30 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms
A23K 10/38 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
[0107] The present invention relates to a composition comprising yeast single cell protein (SCP) product comprising at least about 14% (w/w) essential amino acids per gram of dry yeast SCP product. Preferably, the yeast single cell protein product is produced utilizing ethanol or molasses as a feedstock. The yeast single cell protein product contains advantageously a high ratio of unsaturated versus saturated fatty acids.
The present invention relates to a composition comprising yeast single cell protein (SCP) product comprising at least about 14% (w/w) essential amino acids per gram of dry yeast SCP product. Preferably, the yeast single cell protein product is produced utilizing ethanol or molasses as a feedstock. The yeast single cell protein product contains advantageously a high ratio of unsaturated versus saturated fatty acids.
The present invention relates to a method for cultivating a microorganism, preferably a Saccharomycetales yeast, capable of utilizing mixture of ethanol and methanol as feedstock. The invention is directed to a method for the production of biomass, in particular single cell protein, wherein the yeast single cell protein product comprises Saccharomycetales yeast cells, as well as to an animal feed comprising such biomass.
C12N 1/32 - Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
C12P 1/02 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using fungi
A23J 1/18 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from yeasts
A23J 3/20 - Proteins from microorganisms or unicellular algae
A23K 10/16 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A23K 50/80 - Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
The present invention relates to novel compositions comprising mixtures of cis and trans isomers of retinol, particularly with a cis/trans ratio of less than 1:100, as well as the use of said compositions for preservation.
A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
The present invention relates to a new delivery system for Vitamin C (also known as ascorbic acid and ascorbate) for the release large intestine. These nutritional ingredients are useful for gut and metabolic health in monogastric animals (such as swine and poultry as well as fish), especially in humans.
The present invention relates to use of oligosaccharide preparations to increase average body weight and/or to decrease feed conversion ratio and/or to increase average body weight gain of a bird, and to oligosaccharide preparations for use in treatment, amelioration and/or prophylaxis of a bird vaccinated against coccidiosis.
The present invention relates to a new coating system useful for coating particles, which comprise an active ingredient. Such coated particles, when consumed, do show a controlled release in the human or animal body.
A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/222 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
The present invention relates to a ready to mix composition comprising 30 to 60 wt. % pea and rapeseed protein, 5 to 25 wt. % dietary fiber, 0 to 15 wt. % creaming agent, 1 to 15 wt. % flavor and 0.1 to 5 wt. % hydrocolloid, wherein the ratio of pea and rapeseed protein is within the range of 80:20 to 20:80.
A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
The present invention relates to cosmetic composition comprising the UV-filter Ensulizole, an ester of a fatty acid and dextrin and a mixture of branched and linear saturated C15-C19, wherein said mixture comprised primarily branched saturated C15-C19. This cosmetic composition shows an increased water resistance of the sun protecting factor.
The present invention relates to the use of Vit-D3, 25-OH-D3 and/or 25-OH-D3 and Canthaxanthin improves fertility in birds, preferably poultry, more preferably layers. The present invention further relates to a method to improve fertility in birds comprising a feeding regime and a feed adapted to the age of the bird.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Foodstuffs for animals; Additives to fodder; Formula animal feed not for medical purposes; Animal fattening preparations; Animal beverages; Pet beverages. Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; Biological preparations for use in the manufacture of feed and feed additives; Protein for use in the manufacture of foodstuffs; Proteins for the food industry; Proteins for use in animal feed and feed supplement manufacturing processes; Proteins for use in the manufacture of beverages; Protein for food for human consumption; Proteins for use in the manufacture of food products. Foods and foodstuffs intended for medical or veterinary use; Food supplements for humans and animals; Dietary supplements for humans and animals; Protein supplements for humans and animals; Food for babies; veterinary preparations; Feed additives for animals; Dietetic beverages adapted for medical purposes; Dietary supplement drinks.
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
45 - Legal and security services; personal services for individuals.
Goods & Services
Business assistance and administrative services in the pharmaceutical field; supply chain management services in relation to the pharmaceutical field; retail and wholesale of ingredients for pharmaceuticals. Consultancy relating to pharmaceutical research and development. Pharmaceutical consultation. Legal services and advice in relation to compliance regulations in the pharmaceutical field; consultation in relation to compliance in the pharmaceutical field; regulatory compliance consulting and auditing services for the pharmaceutical industry; reviewing standards and practices to assure compliance with local laws and regulation in relation to the pharmaceutical field.
C07C 403/20 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups
C07D 333/48 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
72.
COMPOSITE SHEETS AND MEDICAL IMPLANTS COMPRISING SUCH SHEETS
Disclosed herein are composite sheets and prosthetic medical devices formed therefrom. In an embodiment, a composite sheet has a thickness of 25-250 μm and comprises 10-70 mass %, based on the total mass of the composite sheet, of a knit fabric having thickness of 15-225 μm and comprising strands of 2-50 dtex, the strands comprising biocompatible polymer fibers, the strands comprising biocompatible polymer fibers, wherein the fabric comprises a thickness in a plurality of first locations, and pores in a plurality of second locations; and 30-90 mass %, based on the total mass of the composite sheet, of a polyurethane coating, wherein the polyurethane coating coats the fabric and fills the pores of the fabric such that the composite sheet is substantially impermeable to water.
A61L 27/48 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
B32B 5/02 - Layered products characterised by the non-homogeneity or physical structure of a layer characterised by structural features of a layer comprising fibres or filaments
B32B 27/12 - Layered products essentially comprising synthetic resin next to a fibrous or filamentary layer
The present invention relates to novel compositions comprising a retinoid mixture of cis and trans isomers of a retinyl ester, particularly retinyl acetate, with a cis/trans ratio of less than 0.03 as well as the use thereof for the treatment, prevention and lessening of the symptoms of diseases and conditions which can be treated with 5-HT2B serotonin receptor antagonists, including but not limited to diseases or conditions selected from migraine headaches, anxiety, ocular hypotension, heart valve disease, irritable bowel syndrome, and MDMA (commonly called “ecstasy”) abuse.
A61K 31/222 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
The present disclosure describes microbial oil compositions that can include a biomass present in a culture medium. The biomass can include a microbial oil enriched in EPA. The present disclosure also describes methods of producing microbial oils enriched in EPA. The present disclosure also describes nutritional oil compositions including the microbial oils and nutritional oil concentrates prepared from the nutritional oil compositions or microbial oils.
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Mixtures of chemicals and microorganisms for increasing the
nutritional value of animal fodder other than for veterinary
use; biological preparations for use in the manufacture of
feed and feed additives; protein for use in the manufacture
of foodstuffs; proteins for the food industry; proteins for
use in animal feed and feed supplement manufacturing
processes; proteins for use in the manufacture of beverages;
protein for food for human consumption; proteins for use in
the manufacture of food products. Foods and foodstuffs intended for medical or veterinary use;
food supplements for humans and animals; dietary supplements
for humans and animals; protein supplements for humans and
animals; food for babies; veterinary preparations; feed
additives for animals; dietetic beverages adapted for
medical purposes; dietary supplement drinks. Foodstuffs for animals; additives to fodder; formula animal
feed not for medical purposes; animal fattening
preparations; animal beverages; pet beverages.
The present invention relates to a lactic acid bacteria composition, a process for the production of a lactic acid bacteria composition using such an additive composition, a starter culture or kit of parts comprising such lactic acid bacteria composition, a process for making a food or feed product, preferably a fermented milk product, using such lactic acid bacteria composition, and the use of such lactic acid bacteria composition in a process for making a food or feed product.
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
A23L 3/00 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
C12N 1/00 - Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor
G16C 20/30 - Prediction of properties of chemical compounds, compositions or mixtures
G06Q 50/00 - Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
80.
PUFA-CONTAINING EDIBLE PRODUCT COMPRISING SHELL AND CENTER FILLING
The present invention relates to an edible product, such as a gummy or confection. In an embodiment, an edible product comprises a filling comprising a polyunsaturated fatty acid oil, an emulsifier, water, and a filling gelling agent, and a shell at least partially surrounding the filling. In an additional embodiment, the shell also comprises a bulking agent and en-capsulated particles comprising a coacervate shell encapsulating a polyunsaturated fatty acid.
Disclosed herein are compositions produced from microorganisms that are capable of producing high levels of docosapentaenoic acid (DPA(n-3)), and methods for producing the compositions. The invention is further directed to microbial strains and derivatives therefrom, biomasses, and microbial oils.
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 35/68 - Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
The present invention relates to a rapeseed protein hydrolysate comprising protein fragments, wherein at least 50% (w/w) of the protein fragments has a molecular weight of less than 3.5 kDa.
The present invention relates to water-soluble or water-dispersible granules that are obtainable by continuous melt granulation. The granules comprise at least one binder, at least one filler and at least one active ingredients. Torque overload may be avoided when using a combination of the herein disclosed filler (e.g. mannitol or an HIMO) and binder (e.g. sorbitol).
A processor system and method (100) are provided for generating a recipe for a thermoplastic compound, wherein the recipe defines a set of ingredients and a relative contribution of the ingredients for manufacturing the thermoplastic compound. The ingredients may comprise additives to be added to a base polymer. The recipe may be generated by training (110) a machine learnable model on compound data (20) of existing (historical) compounds to predict values of compound material properties from an input recipe, providing (120) candidate recipes, selecting 1 (40) a best recipe based on a scoring function, outputting (150) the selected recipe, e.g., via a display, to enable a sample of the compound to be manufactured (200) and measured (210), receiving (160) measurement data of the sample and determining a deviation to a target specification, and determining (170) if the recipe is acceptable. If the recipe is not acceptable, the machine learned model may be retrained or updated based on the measurement data and the recipe of the sample and the above-identified steps may be repeated until a recipe meets the target specification.
The present invention relates to water-soluble or water-dispersible granules that comprise a binder, a filler and an active ingredient. Preferred granules of the invention are obtained by continuous melt granulation of a mixture that comprises 65-70 weight-% active ingredient. 15-25 weight-% filler and 5-15 weight-% binder, based on the total weight of the mixture. Ascorbic acid and edible salts thereof are the preferred active ingredients.
A23P 10/25 - Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
The present application relates to a texture improver. The texture improver comprises curdlan and rapeseed protein at a weight ratio of 1:9 to 9:1. When used in food, particularly in a meat product or a plant-based meat product, the texture improver can remarkably improve the texture and taste of the product, and meets clean food label requirements.
The invention relates to a process for augmenting the protein content of rapeseed protein meal, and to a composition useful in a process for improving the protein content of rapeseed protein meal.
A23J 1/14 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seedsObtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from press-cake or oil-bearing seeds
A23J 3/34 - Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
A23K 10/14 - Pretreatment of feeding-stuffs with enzymes
A23K 10/30 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Additives for food and beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
cultures and fermented preparations of microorganisms for
industrial use for the production of food, beverages, namely
DHA algae oil (docosahexaenoic acid) extracted from algae
strains; microbiologically produced products for industrial
use for the production of food, beverages, namely DHA algae
oil (docosahexaenoic acid) extracted from algae strains;
additives for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; fatty
acids for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; plant
extracts, other than essential oils, for the food industry,
namely DHA algae oil (docosahexaenoic acid) extracted from
algae strains.
90.
GRANULE COMPRISING ENCAPSULATED ACTIVE INGREDIENTS
The present invention relates to water-soluble or water-dispersible granules that are obtainable by continuous melt granulation. In an embodiment, the granules comprise at least one binder, at least one filler and microcapsules that encapsulate fat-soluble active ingredients.
The present invention relates to improved formulations of propandiol mononitrate and derivatives thereof as well as to the methods for production of such formulations.
A23K 10/35 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms from potatoes
A23K 20/28 - Silicates, e.g. perlites, zeolites or bentonites
A23K 30/00 - Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
A23K 40/10 - Shaping or working-up of animal feeding-stuffs by agglomerationShaping or working-up of animal feeding-stuffs by granulation, e.g. making powders
C07C 403/04 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
C07C 403/24 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
93.
ELECTROCHEMICAL OXIDATION OF COMPOUNDS HAVING ALLYLIC C-H BONDS TO YIELD ALPHA,BETA-UNSATURATED KETONES
The present invention relates to the electrochemical oxidation of allylic C- H bonds in specific compounds to obtain specific α,β unsaturated ketones in the presence of t-butyl hydroperoxide. This process is particularly suitable for the electrochemical oxidation of cholesterol, stigmasterol, campesterol, β-sitosterol, brassicasterol, 25-hydroxycholesterol, 24-hydroxycholesterol, lanosterol, pregnenolone, and the esters thereof.
C07J 1/00 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane
C07J 71/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring
The present invention relates to a process for the electrochemical oxidation of allylic C-H bonds in specific compounds to obtain specific α,β-unsaturated ketones.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The smob gene originates from the organism Sulfuriflexus mobilis (https://www.dsmz.de/collection/catalogue/details/culture/DSM-102939), which is a sulfur-oxidizing bacterium isolated from a brackish lake sediment.
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an α-1,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular.
The smob gene originates from the organism Sulfuriflexus mobilis (https://www.dsmz.de/collection/catalogue/details/culture/DSM-102939), which is a sulfur-oxidizing bacterium isolated from a brackish lake sediment.
FIG. 1 should accompany the abstract.
C12N 9/26 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
foodstuffs for animals; Additives to fodder; Formula animal feed not for medical purposes; Animal fattening preparations; Animal beverages; Pet beverages Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; Biological preparations for use in the manufacture of feed and feed additives; Protein for use in the manufacture of foodstuffs; Proteins for the food industry; Proteins for use in animal feed and feed supplement manufacturing processes; Proteins for use in the manufacture of beverages; Protein for food for human consumption; Proteins for use in the manufacture of food products Foods and foodstuffs intended for medical or veterinary use; Food supplements for humans and animals; Dietary supplements for humans and animals; Protein supplements for humans and animals; Food for babies; veterinary preparations; Feed additives for animals; Dietetic beverages adapted for medical purposes; Dietary supplement drinks
The present disclosure relates to the field of food. Herein disclosed is a method for preparing a non-animal protein food product or a cultured meat food product comprising adding a lactase protein preparation to an ingredient used in the preparation of said food product and processing the obtained lactase protein preparation and ingredient composition into a non-animal protein food product or a cultured meat food product.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of: a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out at a temperature of equal to or less than 39°C, preferably equal to or less than 37°C and at a pH setpoint of equal to or less than 5.6, preferably equal to or less than 5.4; b) applying shear to the fermentation broth and optionally concentrating the fermentation broth. Compositions so obtained and use of such compositions.
A process, for the production of a Lactobacillus rhamnosus and/or for the production of a composition comprising a Lactobacillus rhamnosus, wherein the process comprises the steps of: fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of ammonium acetate and wherein the fermentation medium comprises a sodiumhydroxide and/or potassiumhydroxide.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of: a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of acetate or a acetate salt; b) applying shear to the fermentation broth and optionally concentrating the fermentation broth. Compositions so obtained and use of such compositions.
